Immunotherapy with NK cells: recent developments in gene modification open up new avenues

被引：32
作者：
Reindl, Lisa Marie [1 ,2 ]
Albinger, Nawid [1 ,2 ]
Bexte, Tobias [1 ,2 ]
Mueller, Stephan [1 ,2 ]
Hartmann, Jessica [3 ]
Ullrich, Evelyn [1 ,2 ,4 ]
机构：
[1] Goethe Univ Frankfurt, Childrens Hosp, Frankfurt, Germany
[2] Goethe Univ Frankfurt, Expt Immunol, Frankfurt, Germany
[3] Paul Ehrlich Inst, Div Med Biotechnol, Langen, Germany
[4] Goethe Univ, Frankfurt Canc Inst, Frankfurt, Germany
来源：
ONCOIMMUNOLOGY | 2020年 / 9卷 / 01期
关键词：
CAR; NK cells; NK-92; cells; cell therapy; NATURAL-KILLER-CELL; CHIMERIC ANTIGEN RECEPTOR; T-CELLS; MESSENGER-RNA; NK-92; CELLS; HEMATOPOIETIC-CELLS; CORD BLOOD; IN-VITRO; ADOPTIVE TRANSFER; VIVO EXPANSION;
D O I：
10.1080/2162402X.2020.1777651
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Chimeric antigen receptor (CAR)-T cell therapies have achieved remarkable success. However, application-related toxicities, such as cytokine release syndrome or neurotoxicity, moved natural killer (NK) cells into focus as novel players in immunotherapy. CAR-NK cells provide an advantageous dual killing-capacity by CAR-dependent and -independent mechanisms and induce few side effects. While the majority of trials still use CAR-T cells, CAR-NK cell trials are on the rise with 19 ongoing studies worldwide. This review illuminates the current state of research and clinical application of CAR-NK cells, as well as future developmental potential.
引用
收藏
页数：12
相关论文
共 120 条
[11]   REJECTION OF CLASS-I MHC-DEFICIENT HEMATOPOIETIC-CELLS BY IRRADIATED MHC-MATCHED MICE [J].
BIX, M ;
LIAO, NS ;
ZIJLSTRA, M ;
LORING, J ;
JAENISCH, R ;
RAULET, D .
NATURE, 1991, 349 (6307) :329-331
[12]   Comparison of mRNA and lentiviral based transfection of natural killer cells with chimeric antigen receptors recognizing lymphoid antigens [J].
Boissel, Laurent ;
Betancur, Monica ;
Lu, Weiquan ;
Wels, Winfried S. ;
Marino, Teresa ;
Van Etten, Richard A. ;
Klingemann, Hans .
LEUKEMIA & LYMPHOMA, 2012, 53 (05) :958-965
[13]   Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells [J].
Boissel, Laurent ;
Betancura, Monica ;
Wels, Winfried S. ;
Tuncer, Hande ;
Klingemann, Hans .
LEUKEMIA RESEARCH, 2009, 33 (09) :1255-1259
[14]   NK cell education: not an on-off switch but a tunable rheostat [J].
Brodin, Petter ;
Karre, Klas ;
Hoglund, Petter .
TRENDS IN IMMUNOLOGY, 2009, 30 (04) :143-149
[15]   Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C [J].
Campbell, KS ;
Dessing, M ;
LopezBotet, M ;
Cella, M ;
Colonna, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (01) :93-100
[16]   Efficient mRNA-Based Genetic Engineering of Human NK Cells with High-Affinity CD16 and CCR7 Augments Rituximab-Induced ADCC against Lymphoma and Targets NK Cell Migration toward the Lymph Node-Associated Chemokine CCL19 [J].
Carlsten, Mattias ;
Levy, Emily ;
Karambelkar, Amrita ;
Li, Linhong ;
Reger, Robert ;
Berg, Maria ;
Peshwa, Madhusudan V. ;
Childs, Richard W. .
FRONTIERS IN IMMUNOLOGY, 2016, 7
[17]   A Chimeric Receptor with NKG2D Specificity Enhances Natural Killer Cell Activation and Killing of Tumor Cells [J].
Chang, Yu-Hsiang ;
Connolly, John ;
Shimasaki, Noriko ;
Mimura, Kousaku ;
Kono, Koji ;
Campana, Dario .
CANCER RESEARCH, 2013, 73 (06) :1777-1786
[18]   Natural killer cell lines in tumor immunotherapy [J].
Min Cheng ;
Jian Zhang ;
Wen Jiang ;
Yongyan Chen ;
Zhigang Tian .
Frontiers of Medicine, 2012, 6 (1) :56-66
[19]   Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma [J].
Chmielewski, Markus ;
Hombach, Andreas A. ;
Abken, Hinrich .
IMMUNOLOGICAL REVIEWS, 2014, 257 (01) :83-90
[20]   Targeting CD20+ Aggressive B-cell Non-Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG Mice [J].
Chu, Yaya ;
Hochberg, Jessica ;
Yahr, Ashlin ;
Ayello, Janet ;
van de Ven, Carmella ;
Barth, Matthew ;
Czuczman, Myron ;
Cairo, Mitchell S. .
CANCER IMMUNOLOGY RESEARCH, 2015, 3 (04) :333-344
12345678910